By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Currency | US Dollars |
Share Price | $ 750.78 |
Change Today | $ 3.66 |
% Change | 0.49 % |
52 Week High | $960.02 |
52 Week Low | $713.71 |
Volume | 3,056,488 |
Shares Issued | 948.17m |
Market Cap | $711,867m |
Beta | 0.70 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
15:59 | 119 @ $751.06 |
15:59 | 100 @ $750.87 |
15:59 | 100 @ $750.87 |
15:59 | 100 @ $750.90 |
15:59 | 110 @ $751.08 |
You are here: research